FCX-007

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
36	表皮水疱症	1

36. 表皮水疱症

臨床試験数 : 163 / 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02810951 (ClinicalTrials.gov)	July 1, 2016	13/6/2016	A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)	A Phase I/II Study of FCX-007(Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessiv ...	Epidermolysis Bullosa Dystrophica, Recessive	Genetic: FCX-007	Castle Creek Biosciences, LLC.	NULL	Terminated	7 Years	N/A	All	6	Phase 1/Phase 2	United States

First Previous1Next Last